Infinium Global Research Ophthalmic Drugs Market | Page 2

A latest report has been added to the wide database of Ophthalmic Drugs Market by Infinium Global Research. This report studies the
Ophthalmic Drugs Market by disease condition (allergy, glaucoma, dry eye disorder and retinal disorder), dispenses type (prescription
and over the counter) market status and outlook of global and major regions, from manufacturers, and end industries. The objective of
the study is to identify market sizes of different segments & countries in recent years and to forecast the values for the next six years.
Ophthalmic Drugs Market provides opportunities in micro markets for stakeholders to invest along with the detailed analysis of
competitive landscape, latest trends, and product offerings of the major companies in the Ophthalmic Drugs Market. According to
report the global ophthalmic drugs market is projected to grow at a CAGR of 5.4% over the forecast period of 2017-2023.
Ophthalmic drugs are the drugs designed for the treatment of eye diseases and disorders. This administration of drug can be done by
instillation of a cream, an ointment, or a liquid drop preparation in the conjunctiva SAC. The correct strength and amount of the drug
are selected, and the medication is instilled into the eye or eyes as directed. The main reason of continuingly strong interest of
scientists in these drugs forms is the problem of a low bioavailability of medicinal substance after the application to the eyeball. The
ability to increase the bioavailability of the active substances, reducing the susceptibility of drug forms to defense mechanisms of the
human eye, extending contact time of drug with the cornea, increasing the penetration through the complex anatomical structure of
the eye, and providing controlled release of drugs into the eye tissues which allows reducing the drug application frequency, witnesses
the importance of ophthalmic drugs among the aging population suffering from eye disorders are some of the factors contributing to
the growth in the global ophthalmic drugs market.
Market Insights
The key factors driving the growth of ophthalmic drugs market are considered to be increasing geriatric population with rising global
population, increase in prevalence of eye disorders, technological advancement, and increasing awareness in healthcare spending.
Moreover, challenges faced by ophthalmic drugs market include absence of health insurance in developing countries regarding eye
diseases and lack of awareness among the people regarding eye diseases and disorders in underdeveloped and developing countries.
One of the key opportunities for new entrants is securing drugs through a licensing agreement with major players such as novartis and
bayer, which could boost their growth over the forecast period.
Segment Covered
The report on global ophthalmic drugs market covers segments such as, disease condition and dispenses type. On the basis of disease